Amicus stock surges on positive 2024 revenue outlook By Investing.com
Investing.com — Shares of Amicus Therapeutics (NASDAQ:) jumped 9% as the biotech company provided an optimistic preliminary revenue outlook for…
Read MoreInvesting.com — Shares of Amicus Therapeutics (NASDAQ:) jumped 9% as the biotech company provided an optimistic preliminary revenue outlook for…
Read More